Archives des Publications - Page 33 sur 44 - Prestwick Chemical Libraries

Publications


Publications
Deciphering the antitumoral activity of quinacrine: Binding to and inhibition of Bcl-xL

Bioorganic and Medicinal Chemistry Letters

Orzáez M, Mondragón L, García-Jareño A, Mosulén S, Pineda-Lucena A, Pérez-Payá E
Bioorganic and Medicinal Chemistry Letters - vol. 19 1592-1595 (2009)

From the screening of a unique collection of 880 off-patent small organic molecules, we have found that quinacrine inhibits the interaction between a BH3 domain-derived peptide and the antiapoptotic protein Bcl-xL. Nuclear magnetic resonance spectroscopy confirmed that quinacrine binds to the hydrophobic groove that Bcl-xL uses for interacting with the BH3 domain of proapoptotic proteins. […]

Publications
Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy.

Journal of Virology

Porotto M, Orefice G, Yokoyama CC, Mungall BA, Realubit R, Sganga ML, Aljofan M, Whitt M, Glickman F, Moscona A
Journal of Virology - vol. 83 5148-5155 (2009)

Nipah (NiV) and Hendra (HeV) viruses are emerging zoonotic paramyxoviruses that cause encephalitis in humans, with fatality rates of up to 75%. We designed a new high-throughput screening (HTS) assay for inhibitors of infection based on envelope glycoprotein pseudotypes. The assay simulates multicycle replication and thus identifies inhibitors that target several stages of the viral […]

Publications
Automated high-content screening for compounds that disassemble the perinucleolar compartment.

Journal of biomolecular screening

Norton JT, Titus SA, Dexter D, Austin CP, Zheng W, Huang S
Journal of biomolecular screening - vol. 14 1045-1053 (2009)

All solid malignancies share characteristic traits, including unlimited cellular proliferation, evasion of immune regulation, and the propensity to metastasize. The authors have previously described that a subnuclear structure, the perinucleolar compartment (PNC), is associated with the metastatic phenotype in solid tumor cancer cells. The percentage of cancer cells that contain PNCs (PNC prevalence) is indicative […]

Publications
Hit finding: towards ‘smarter’ approaches

Current Opinion in Pharmacology

Langer T, Hoffmann R, Bryant S, Lesur B
Current Opinion in Pharmacology - vol. 9 589-593 (2009)

Drug discovery is complex and risky, and the chances of success are low. One starting point to discover a new drug is the selective screening of a collection of high value and good quality compounds. Selection of compounds for screening is one of the challenging initial steps in the drug discovery process and is crucial […]

Publications
Inhibiting the calcineurin-NFAT (nuclear factor of activated T cells) signaling pathway with a regulator of calcineurin-derived peptide without affecting general calcineurin phosphatase activity

Journal of Biological Chemistry

Journal of Biological Chemistry - vol. 284 9394-9401 (2009)

Calcineurin phosphatase plays a crucial role in T cell activation. Dephosphorylation of the nuclear factors of activated T cells (NFATs) by calcineurin is essential for activating cytokine gene expression and, consequently, the immune response. Current immunosuppressive protocols are based mainly on calcineurin inhibitors, cyclosporine A and FK506. Unfortunately, these drugs are associated with severe side […]

Publications
Monitoring Compound Integrity with cytochrome P450 assays and qHTS

Www.Sbsonline.Org

MacArthur R, Leister W, Veith H, Shinn P, Southall N, Austin CP, Inglese J, Auld DS
Www.Sbsonline.Org 1-9 (2009)

The authors describe how room temperature storage of a 1120-member compound library prepard in either DMSO or in a hydrated-DMSO/water (67/33) mixture affects the reproducibility of potency values as monitored using cytochrome P450 1A2 and 2D6 isozyme assays. The bioluminescent assays showed Z’factors of 0.71 and 0.62, with 17% and 32% of the library found […]

Publications
Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization.

The Biochemical journal

Iorns E, Lord CJ, Ashworth A
The Biochemical journal - vol. 417 361-370 (2009)

Tamoxifen is the most commonly used drug to treat breast cancer and acts by blocking ERalpha (oestrogen receptor alpha) signalling. Although highly effective, its usefulness is limited by the development of resistance. Given this, strategies that limit resistance by sensitizing cells to tamoxifen may be of use in the clinic. To gain insight into how […]

Publications
Parallel Functional Activity Profiling Reveals Valvulopathogens Are Potent 5-Hydroxytryptamine 2B Receptor Agonists : Implications for Drug Safety Assessment □

Molecular Pharmacology

Huang X, Setola V, Yadav PN, Allen JA, Rogan SC, Hanson BJ, Revankar C, Robers M, Doucette C, Roth BL
Molecular Pharmacology - vol. 5 710-722 (2009)

Drug-induced valvular heart disease (VHD) is a serious side effect of a few medications, including some that are on the market. Pharmacological studies of VHD-associated medications (e.g., fenfluramine, pergolide, methysergide, and cabergoline) have revealed that they and/or their metabolites are potent 5-hydroxytryptamine2B (5-HT2B) receptor agonists. We have shown that activation of 5-HT2B receptors on human […]

Publications
Establishment of human papillomavirus infection requires cell cycle progression

PLoS Pathogens

Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF
PLoS Pathogens - vol. 5 (2009)

Human papillomaviruses (HPVs) are DNA viruses associated with major human cancers. As such there is a strong interest in developing new means, such as vaccines and microbicides, to prevent HPV infections. Developing the latter requires a better understanding of the infectious life cycle of HPVs. The HPV infectious life cycle is closely linked to the […]

Publications
Cardiac glycosides induce cell death in human cells by inhibiting general protein synthesis

PLoS ONE

Perne A, Muellner MK, Steinrueck M, Craig-Mueller N, Mayerhofer J, Schwarzinger I, Sloane M, Uras IZ, Hoermann G, Nijman SMB, Mayerhofer M
PLoS ONE - vol. 4 (2009)

BACKGROUND: Cardiac glycosides are Na(+)/K(+)-pump inhibitors widely used to treat heart failure. They are also highly cytotoxic, and studies have suggested specific anti-tumor activity leading to current clinical trials in cancer patients. However, a definitive demonstration of this putative anti-cancer activity and the underlying molecular mechanism has remained elusive.nnMETHODOLOGY/PRINCIPAL FINDINGS: Using an unbiased transcriptomics approach, […]